Recruiting Atopic Dermatitis Studies in Cerritos
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1305/BNT325 in subjects with advanced solid tumors....
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
The primary objective of this phase I study is to evaluate the safety and potential efficacy and to determine the recommended phase 2 dose (RP2D) of CBP-1019, a bi-specific ligand conjugated drugs in ...
About Atopic Dermatitis Clinical Trials in Cerritos
Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.
There are currently 2 atopic dermatitis clinical trials recruiting participants in Cerritos, CA. These studies are seeking a combined 1,383 participants. Research is being sponsored by DualityBio Inc., Coherent Biopharma (Hefei) Co., Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atopic Dermatitis Clinical Trials in Cerritos — FAQ
Are there atopic dermatitis clinical trials in Cerritos?
Yes, there are 2 atopic dermatitis clinical trials currently recruiting in Cerritos, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Cerritos?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cerritos research site will contact you about next steps.
Are clinical trials in Cerritos free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cerritos studies also compensate for your time and travel.
What atopic dermatitis treatments are being tested?
The 2 active trials in Cerritos are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.
Data updated March 2, 2026 from ClinicalTrials.gov